Sino Medical Sciences Technology Inc. (688108.SS)
CNY 10.24
(-0.49%)
CNY 10.24
(-0.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -39.63 Million CNY | 71.54% |
| 2022 | -173.31 Million CNY | -32.0% |
| 2021 | -131.29 Million CNY | -683.72% |
| 2020 | 22.49 Million CNY | -75.02% |
| 2019 | 90.03 Million CNY | 0.95% |
| 2018 | 89.19 Million CNY | 34.84% |
| 2017 | 66.14 Million CNY | 130.87% |
| 2016 | 28.65 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -14.4 Million CNY | -379.01% |
| 2024 Q1 | 2.49 Million CNY | 153.35% |
| 2024 Q2 | 5.16 Million CNY | 106.65% |
| 2023 Q4 | -4.68 Million CNY | 61.4% |
| 2023 Q2 | -13.4 Million CNY | 28.11% |
| 2023 FY | -49.31 Million CNY | 71.54% |
| 2023 Q3 | -12.13 Million CNY | 9.46% |
| 2023 Q1 | -18.64 Million CNY | 68.04% |
| 2022 Q3 | -40.34 Million CNY | 9.03% |
| 2022 FY | -173.31 Million CNY | -32.0% |
| 2022 Q4 | -58.34 Million CNY | -44.59% |
| 2022 Q2 | -44.35 Million CNY | -46.56% |
| 2022 Q1 | -30.26 Million CNY | -54.16% |
| 2021 Q3 | -29.59 Million CNY | 26.48% |
| 2021 Q2 | -40.24 Million CNY | 2.53% |
| 2021 Q4 | -19.63 Million CNY | 33.66% |
| 2021 FY | -131.29 Million CNY | -683.72% |
| 2021 Q1 | -41.29 Million CNY | -55.59% |
| 2020 FY | 22.49 Million CNY | -75.02% |
| 2020 Q4 | -26.54 Million CNY | -250.17% |
| 2020 Q3 | 17.67 Million CNY | -24.75% |
| 2020 Q2 | 23.48 Million CNY | 198.22% |
| 2020 Q1 | 7.87 Million CNY | -67.56% |
| 2019 FY | 90.03 Million CNY | 0.95% |
| 2019 Q2 | 24.2 Million CNY | 3.88% |
| 2019 Q1 | 23.3 Million CNY | -7.79% |
| 2019 Q4 | 24.27 Million CNY | 33.05% |
| 2019 Q3 | 18.24 Million CNY | -24.62% |
| 2018 Q4 | 25.27 Million CNY | 0.0% |
| 2018 Q1 | 22.27 Million CNY | 0.0% |
| 2018 FY | 89.19 Million CNY | 34.84% |
| 2017 FY | 66.14 Million CNY | 130.87% |
| 2016 FY | 28.65 Million CNY | 0.0% |